Insider trades

Versant Venture Capital VI, 10% Owner of Lenz Therapeutics LENZ, has filed 0 purchases and 52 sales on the open market. The latest trade was on 25/09/30.

Versant Venture Capital VI

10% Owner
First filing
23/01/04
Trades
88 trades
Buys / sales
0 / 52
12-month net buying
No record
Last trade
25/09/30

Trading activity

Transactions

Trade type
LENZ
Open-market sale25/09/3025/10/02224,974 sh6 trades$46.01avg.$10,352,070.98No record
Open-market sale25/09/1925/09/232,903,403 sh2 trades$1.40avg.$4,064,764.2No record
LENZ
Open-market sale25/09/1825/09/22135,304 sh6 trades$42.23avg.$5,714,064.91No record
Open-market sale25/09/16–25/09/1825/09/181,684,434 sh6 trades$1.48avg.$2,500,061.56No record
LENZ
Open-market sale25/08/22–25/08/2625/08/26188,094 sh12 trades$39.47avg.$7,423,963.67No record
LENZ
Open-market sale25/08/15–25/08/1825/08/19260,713 sh4 trades$39.34avg.$10,255,193.28No record
Open-market sale25/07/1025/07/14191,376 sh$34.00$6,506,784−10.8%
Open-market sale25/06/2725/07/01200,000 sh$30.47$6,094,000−10.2%
LENZ
Open-market sale25/06/18–25/06/2025/06/20334,801 sh3 trades$30.19avg.$10,107,817.95No record
Open-market sale25/06/1025/06/12350,000 sh$29.00$10,150,000−21.9%
GLUE
Open-market sale24/10/28–24/10/2924/10/30157,895 sh3 trades$9.44avg.$1,491,028.8−9.1%
Open-market sale24/09/2024/09/241,132,566 sh$6.53$7,395,655.98−18.2%
GLUE
Open-market sale24/09/11–24/09/1324/09/13567,213 sh3 trades$6.00avg.$3,404,761.04−8.3%
Open-market sale24/08/2824/08/30221,600 sh$6.32$1,400,512−5.6%
TPST
Open-market sale24/08/08–24/08/1224/08/12787,999 sh2 trades$1.23avg.$966,798.9−79.0%